LCS16 vs. COC User Satisfaction and Tolerability Study
Condition: Contraception Interventions: Drug: Levonorgestrel (Kyleena, BAY86-5028); Drug: Ethinyl estradiol and drospirenone (Yarina, BAY86-5131) Sponsor: Bayer Not yet recruiting - verified March 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 3, 2017 Category: Research Source Type: clinical trials
Oral Contraceptives as Infertility Treatments for Premature Ovarian Failure
Conditions: Primary Ovarian Insufficiency; Menopause, PrematureIntervention: Drug: Drospirenone and ethinyl estradiol combination (Yasmin)Sponsor: Navy General Hospital, BeijingNot yet recruiting - verified April 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2016 Category: Research Source Type: clinical trials
Study of Treatment With the Combination of Drospirenone Plus Ethinyl Estradiol Plus Levomefolate Calcium in Mexican Women Seeking Contraception
Condition: ContraceptionIntervention: Drug: EE20/DRSP/L-5-MTHF (Beyaz, BAY98-7071)Sponsor: BayerActive, not recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 15, 2013 Category: Research Source Type: clinical trials
Study of Treatment With the Combination of Drospirenone Plus Ethinyl Estradiol Plus Levomefolate Calcium in Mexican Women Seeking Contraception
Condition: ContraceptionIntervention: Drug: EE20/DRSP/L-5-MTHF (Beyaz, BAY98-7071)Sponsor: BayerActive, not recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 15, 2013 Category: Research Source Type: clinical trials
Study of Treatment With the Combination of Drospirenone Plus Ethinyl Estradiol Plus Levomefolate Calcium in Mexican Women Seeking Contraception
Condition: ContraceptionIntervention: Drug: EE20/DRSP/L-5-MTHF (Beyaz, BAY98-7071)Sponsor: BayerActive, not recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 15, 2013 Category: Research Source Type: clinical trials
Study of Treatment With the Combination of Drospirenone Plus Ethinyl Estradiol Plus Levomefolate Calcium in Mexican Women Seeking Contraception
Condition: ContraceptionIntervention: Drug: EE20/DRSP/L-5-MTHF (Beyaz, BAY98-7071)Sponsor: BayerActive, not recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 15, 2013 Category: Research Source Type: clinical trials
A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS
Condition: Hidradenitis SuppurativaInterventions: Drug: drospirenone and ethinyl estradiol (YAZ); Drug: PlaceboSponsors: Massachusetts General Hospital; BayerTerminated - verified January 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 24, 2008 Category: Research Source Type: clinical trials
Treatment of Vasomotor Symptoms in Korean Post Menopausal Women
Condition: Vasomotor SymptomsInterventions: Drug: Angeliq (Drospirenone/17ß-estradiol, BAY86-4891); Drug: PlaceboSponsor: BayerCompleted - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2008 Category: Research Source Type: clinical trials
Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms.
Condition: Vasomotor SymptomsInterventions: Drug: Estradiol/DRSP (Angeliq, BAY86-4891); Drug: PlaceboSponsor: BayerCompleted - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2006 Category: Research Source Type: clinical trials
